# Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)

> **NCT02809404** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 75 (actual)

## Conditions studied

- Breast Cancer
- Renal Cell Carcinoma

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT02809404
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-01
- **Final completion:** 2017-01
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2017-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02809404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02809404, "Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02809404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*